Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.23 USD | -0.78% | -0.46% | +16.96% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2024 P/E ratio at 26.56 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's enterprise value to sales, at 4.15 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.96% | 7.65TCr | A+ | ||
+12.72% | 39TCr | C- | ||
+15.76% | 14TCr | B- | ||
-6.40% | 7.12TCr | A- | ||
-22.04% | 4.09TCr | B+ | ||
-16.58% | 3.44TCr | - | ||
+7.92% | 3.56TCr | B- | ||
+10.44% | 1.88TCr | A- | ||
+24.46% | 1.74TCr | B | ||
+9.49% | 1.32TCr | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CL Stock
- Ratings Colgate-Palmolive Company